Nuclear Factor 1 and T-Cell Factor/LEF Recognition Elements Regulate Pitx2 Transcription in Pituitary Development by Ai, Di et al.
MOLECULAR AND CELLULAR BIOLOGY, Aug. 2007, p. 5765–5775 Vol. 27, No. 16
0270-7306/07/$08.000 doi:10.1128/MCB.01848-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Nuclear Factor 1 and T-Cell Factor/LEF Recognition Elements
Regulate Pitx2 Transcription in Pituitary Development
Di Ai, Jun Wang, Melanie Amen, Mei-Fang Lu, Brad A. Amendt, and James F. Martin*
Institute of Biosciences and Technology, Texas A&M System Health Science Center, 2121 Holcombe Blvd, Houston, Texas 77030
Received 29 September 2006/Returned for modification 17 January 2007/Accepted 21 May 2007
Pitx2, a paired-related homeobox gene that is mutated in Rieger syndrome I, is the earliest known marker
of oral ectoderm. Pitx2 was previously shown to be required for tooth, palate, and pituitary development in
mice; however, the mechanisms regulating Pitx2 transcription in the oral ectoderm are poorly understood. Here
we used an in vivo transgenic approach to investigate the mechanisms regulating Pitx2 transcription. We
identified a 7-kb fragment that directs LacZ expression in oral ectoderm and in many of its derivatives.
Deletion analysis of transgenic embryos reduced this fragment to a 520-bp region that directed LacZ activity
to Rathke’s pouch. A comparison of the mouse and human sequences revealed a conserved nuclear factor 1
(NF-1) recognition element near a consensus T-cell factor (TCF)/LEF binding site. The mutation of either site
individually abolished LacZ activity in transgenic embryos, identifying Pitx2 as a direct target of Wnt signaling
in pituitary development. These findings uncover a requirement for NF-1 and TCF factors in Pitx2 transcrip-
tional regulation in the pituitary and provide insight into the mechanisms controlling region-specific tran-
scription in the oral ectoderm and its derivatives.
The primitive oral ectoderm, originally derived from head
ectoderm, gives rise to teeth, salivary glands, and the pituitary
(9). As development proceeds, signaling interactions between
oral ectoderm and the underlying mesoderm or neural ecto-
derm promote organogenesis. In the mandible, signals from
the oral ectoderm are known to instructively pattern the un-
derlying mesenchyme. Regional expression of signaling mole-
cules, such as Bmp4 and Fgf8, imposes pattern information on
the mandibular mesenchyme and establishes the initial proxi-
modistal pattern of the mandible (29, 32, 45). While much
work has focused on epithelial-mesenchymal signaling, less is
known about the molecular mechanisms that define region-
specific gene transcription during oral ectoderm diversifica-
tion.
The Pitx (pituitary homeobox) family of homeobox genes
contains three genes, Pitx1, Pitx2, and Pitx3, within the larger
paired-related superfamily of homeobox genes (17, 37). The
Pitx group, a remarkably important gene subfamily, has been
implicated in human development, disease, and evolution (39–
41). For example, Pitx2 is the gene mutated in Rieger syn-
drome I that results in ocular, tooth, and body wall defects
(40). A regulatory mutation in Pitx1 has been implicated in the
evolution of the pelvis in threespine sticklebacks (41). The last
member of the family, Pitx3, is the gene mutated in patients
with congenital cataracts and ocular anterior segment defects
(39).
Previous studies have shown that Pitx2 is the earliest marker
of the oral ectoderm (33); moreover, as the oral ectoderm
diversifies into an organ-forming epithelium, such as the dental
epithelium or Rathke’s pouch (RP), Pitx2 expression becomes
restricted to this maturing epithelium. Consistent with the
Pitx2 expression pattern, loss-of-function experiments in mice
uncovered an important function for Pitx2 in tooth and pitu-
itary development (16, 24, 25, 28, 30); moreover, Pitx2 was
critical for left-right asymmetry, a fundamental component of
vertebrate organ morphogenesis, in addition to ocular and
abdominal wall morphogenesis (26, 27, 30).
Pitx2 played a critical role in pituitary development through
a mechanism that involves both proliferation and cell survival
(10, 23). Pitx2 has been shown to regulate Pit-1, PLOD-1, and
LEF-1 (1, 20, 46). Other work has also indicated that the
Hesx1/Rpx1 homeobox gene is a direct target of Pitx genes in
the pituitary (11, 16).
Because of its critical role as a late effector of the left-right
asymmetry signaling pathways, Pitx2 transcriptional regulation
in the left lateral plate mesoderm has been studied. Transgenic
analysis of Pitx2 gene regulation uncovered separable mecha-
nisms controlling Pitx2 in the lateral plate and in maturing
organs. In the lateral plate, Pitx2 expression was dependent
upon a Nodal-FoxH1 pathway that functioned through an in-
tergenic enhancer termed the asymmetric element (ASE). In
the organ primordia, Pitx2 maintenance was regulated by an
Nkx element also contained within the ASE (42, 43). It is
unknown whether similar two-step mechanisms apply to Pitx2
regulation in the oral ectoderm and organ-forming epithelium.
Although Pitx2 transcriptional regulation in oral ectoderm
has not been studied directly in vivo, bead implantation exper-
iments indicated that Fgf8 has a positive influence, while Bmp4
restricts Pitx2 in the forming of dental epithelium (44).
Whether the influence of Fgf8 and Bmp4 on Pitx2 expression is
direct or distant, downstream events are unknown. Other ex-
periments, performed in tissue culture, implicated Pitx2 as a
direct target of Wnt signaling in pituitary and skeletal muscle
cells (23). A clear picture of the mechanisms regulating Pitx2
expression in the oral ectoderm and organ-forming epithelium
within the whole embryo is lacking.
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To gain insight into the mechanisms regulating Pitx2 expres-
sion in the oral and dental epithelium, we used a series of
transgenic reporter genes to define a Pitx2 oral ectoderm en-
hancer element. We uncovered a 7-kb region 3 of Pitx2 coding
sequences that directed LacZ expression in oral ectoderm.
A deletion analysis of this oral ectoderm element uncovered
a subregion that directed LacZ expression in RP, an RP en-
hancer; moreover, in the RP enhancer we found that nuclear
factor 1 (NF-1) and T-cell factor (TCF)/LEF binding sites were
required for enhancer activity. These findings reveal that NF-1
and TCF/LEF factors regulate Pitx2 in RP and implicate Pitx2
as a direct target of Wnt signaling in early pituitary develop-
ment.
MATERIALS AND METHODS
Generation of reporter constructs. A Pitx2 genomic clone was isolated from a
mouse 129SV genomic bacterial artificial chromosome library by using the Pitx2
cDNA as a probe. Construct tg1k is a 16-kb Pitx2 genomic fragment encompass-
ing the Pitx2c promoter (P2) and 4.2 kb downstream of exon 6 (Fig. 1A).
Construct tg3k was generated by adding a 7-kb endogenous genomic fragment
that was amplified from a bacterial artificial chromosome using a high-fidelity
PCR system (Roche) with two oligonucleotides, 5-GTTTAAACGGCCGGCC
GAGACTAATTAGTTGCTCCC and 3-GTTTAAACTGGCGCGCCCTGAT
TGAGTAAAATATCTTTG (two PmeI cutting sites flanking the 7-kb fragment
were introduced for subcloning). tg2k was generated by deleting an upstream
2.8-kb fragment of tg3k. Construct tg3k-Del:5821-9918 was made by deleting a
4-kb fragment in the middle of the 7-kb fragment from tg3k by recombineering
(see below). A promoterless LacZ cassette, which has the LacZ coding sequence
and poly(A), was inserted into the 5 untranscribed region of Pitx2 exon4 (the
first exon of Pitx2c) in tg1k, tg2k, tg3k, and tg3k-Del:5821-9918 as a reporter.
Other constructs were amplified using a high-fidelity PCR system (Roche) and
subcloned into the Hsp68 LacZ hybrid reporter cassette. All PCR products were
sequenced to make sure no mutations were introduced.
Recombineering. Recombineering was used to delete a 4-kb fragment from
tg3k to make tg3k-Del:5821-9918. The targeting vector has two 500-bp homol-
ogous arms with a floxed chloramphenicol cassette in the middle. Two homolo-
gous arms were amplified by PCR, 5 arm oligonucleotides (CTCGAGCTGTG
ACTGCCCACCGATCCC and AAGCTTCGCTGGGATAGCTGCTATGAG)
and 3 arm oligonucleotides (GGATCCGATGCCAGACAAGTGCTAGC and
GCGGCCGCCATCTGTAGTGGAATCTGATGCCC). tg3k was first electro-
porated into the EL350 cell (12). A single colony was inoculated and cultured
overnight at 32°C. The next morning, the culture was diluted (1:50) and cultured
until the optical density at 600 nm was 0.5. Then the cells were activated at 42°C
for exactly 15 min, cooled down, and washed with ice-cold double-distilled water
three times. Three hundred nanograms of targeting vector DNA was electropo-
rated into activated cells, and positive clones were selected on plates containing
chloramphenicol (25 g/ml). Targeted clones were screened and induced to
express Cre recombinase by a 1-h culture with 0.1% L-arabinose in LB to remove
the chloramphenicol cassette.
Generation and analysis of transgenic mice. All transgenic constructs were
digested and gel purified using a spin column kit (QIAGEN) and eluted in 1
microinjection buffer (10 mM Tris, 0.1 mM EDTA, pH 7.4). One nanogram per
fertilized zygote of purified transgene was injected into the male pronuclei of
embryonic day 0.5 fertilized zygotes from FVB mice. Injected zygotes were
transferred back to ICR pseudopregnant females, and embryos were harvested at
the desired embryonic time points indicated in the text. DNAs of transgenic
founders were analyzed by Southern blotting, and DNAs of embryos were ana-
lyzed by PCR with either tail snip or yolk sac genomic DNA. LacZ genotyping
primers were the 5 primer, 5-GCA TCG AGC TGG GTA ATA AGG GTT
GGC AAT-3, and the 3 primer, 5-GAC ACC AGA CCA ACT GGT AAT
GGT AGC GAC-3, producing a 700-bp LacZ-specific product. Embryos from
sacrificed mice were dissected. Yolk sacs were removed for LacZ PCR genotyp-
ing. Embryos were fixed in 2% formaldehyde and 0.2% glutaraldehyde in phos-
phate-buffered saline, washed at room temperature, and then stained overnight
in staining buffer [1 mg/ml X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyr-
anoside), 5 mM K3Fe(CN)6 and 5 mM K4Fe(CN)6 in phosphate-buffered sa-
line]. For sections, X-gal-stained embryos were dehydrated in a series of 70, 95,
and 100% ethanol, embedded in paraffin, sectioned at a thickness of 8 m, and
counterstained with eosin.
Site-directed mutagenesis. Site-directed mutagenesis of the NF-1 and LEF-1
sites was achieved by using the QuikChange II XL site-directed mutagenesis kit
(Stratagene). The DNA fragments used for mutagenesis were cloned into the
pGEM T-Easy vector (Promega) first, and mutated fragments were then excised
and subcloned into the vector with the Hsp68 LacZ cassette to make tg5k-NF-1
M and tg5k-LEF-1 M (see Fig. 6). The sense-strand sequences of the oligonu-
cleotides used for mutation were 5-CCCTTACTGTCTTCTATCGCACATCG
ATCGGTTTTACTTTG-3 for NF-1 and 5-CCCAGCCAAGGTTTTAGCTA
GTTTTCTTTTGCTG-3 for LEF-1 (underlined letters indicate the mutant
NF-1 and LEF-1 sites). All mutations were confirmed by DNA sequencing. The
same mutations were introduced into the NF-1 and LEF-1 sites for the electro-
phoretic mobility shift assay (EMSA).
EMSA. The NucBuster protein extraction kit (Novagen) was used to pre-
pare T3-1 cell nuclear extracts, and a TNT-coupled reticulocyte lysate sys-
tem (Promega) was used to synthesize NF-1X protein in vitro. Purified LEF-1
protein was used for the TCF/LEF gel shift. Briefly, double-stranded oligo-
nucleotides were annealed and end labeled with [-32P]dATP using T4
polynucleotide kinase (NEB). Labeled probes were purified using a Micro
Bio-Spin 6 column (Bio-Rad). Binding reaction mixtures were incubated in
ice in 1 binding buffer (100 mM KCl, 20 mM HEPES, 0.5 mM dithiothreitol,
0.2 mM EDTA) containing 10 g nuclear extract or 2 g recombinant NF-1X
protein or 0.2 g purified LEF-1 protein, 1 g of poly(dI-dC) for 5 min and
another 5 min after competitor oligonucleotides (100-fold excess) were
added. The reaction mixtures were incubated in ice for an additional 15 min
after the addition of the probe and another 30 min after the addition of the
antibodies. Reaction mixtures were electrophoresed on a 5% nondenaturing
polyacrylamide gel. The sense-strand sequences of the oligonucleotides used
for EMSAs were 5-CTTCTTTGTACCCAGCCAAGGTTTTAC-3 for the
wild-type NF-1 site, 5-CTTCTATCGCACATCGATCGGTTTTAC-3 for
the mutant NF-1 site, 5-CCCAGCCAAGGTTTTACTTTGTTTTCTTTTGC
TG-3 for the wild-type LEF-1 site, and 5-CCCAGCCAAGGTTTTAGCTA
GTTTTCTTTTGCTG-3 for the mutant LEF-1 site (underlined letters indi-
cate the wild-type and mutated binding sites).
ChIP analysis. The chromatin immunoprecipitation (ChIP) analysis was per-
formed using a ChIP assay kit (Upstate) as previously described (14). The two
primers for amplifying the LEF-1 and NF-1 binding sites in the Pitx2c promoter
were sense, 5-GCTCCCCAATCACTGTGTGTACGTGT-3, and antisense, 5-
TTGGGGGCTGCAACCAGCTGCTGGCTGAAGG-3. All the PCR products
were evaluated for appropriate size (390 bp) on a 2% agarose gel in 1 Tris-
borate-EDTA and were confirmed by sequencing. As controls, the Pitx2c primers
were used without chromatin, normal rabbit immunoglobulin G was used as a
replacement for the LEF-1 (Upstate) or NF-1 antibody (Santa Cruz) to reveal
nonspecific immunoprecipitation of the chromatin, and primers to an unrelated
gene were used to demonstrate the specificity of the LEF-1 or NF-1 antibody-
immunoprecipitated chromatin.
RESULTS
A Pitx2c oral ectoderm enhancer element in the 3 flanking
region. The Pitx2 gene encodes three isoforms, Pitx2a, Pitx2b,
and Pitx2c, which are generated by a combination of alterna-
tive splicing and alternative promoter usage and have overlap-
ping expressions in oral ectoderm (24, 38). To identify cis-
acting elements regulating Pitx2 in oral ectoderm, we used a
plasmid containing 16 kb of Pitx2 genomic sequences contain-
ing Pitx2 exons 4 through 6. We introduced a LacZ cassette
into the Pitx2c-specific exon 4 to generate a construct, tg1k,
that directed expression in the heart but not the oral ectoderm
(Fig. 1A) (42, 43).
To scan sequences downstream of Pitx2 for elements that
direct Pitx2c expression in oral ectoderm, we added a 7-kb
fragment to the 3 end of tg1K, to generate a plasmid referred
to as tg3k (Fig. 1A). We also tested a construct that contained
the 7-kb downstream sequences in the context of a small (2.8
kb) 5 deletion (referred to as tg2K) (Fig. 1A). Both tg2k and
tg3k directed LacZ activity in the oral ectoderm with high
efficiency. To better define the oral ectoderm enhancer, we
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introduced a 4-kb deletion in the 7-kb fragment in the context
of the tg3k construct (tg3k D5821-9918). Embryos with tg3k
D5821-9918 still expressed LacZ in the oral ectoderm, indicat-
ing that the enhancer element was located at either end of the
7-kb fragment (Fig. 1A).
Expression of the Pitx2c oral ectoderm enhancer during
development. To determine whether the Pitx2c oral ectoderm
enhancer completely recapitulated endogenous Pitx2c expres-
sion, we performed a developmental time course using the
stable tg3k and tg3k D5821-9918 lines. Two stable transgenic
lines were evaluated for both the tg3k and the tg3k D5821-9918
constructs. All stable lines gave comparable results, although
the levels of LacZ activity varied and there was more ectopic
LacZ activity in the tg3k D5821-9918 lines, suggesting that the
FIG. 1. Identification of a Pitx2c oral ectoderm and RP enhancer. Shown at the top of panel A is a representation of the genomic fragment that
covers the Pitx2c promoter region (P2); exons 4, 5, and 6; and flanking regions. Construct names are indicated on the left, and the corresponding
expression patterns are summarized on the right. The “# with expression” column shows the number of transgenic lines with positive RP and oral
ectoderm staining per total number of transgenic lines. Asterisks indicate stable lines that were analyzed in multiple stages. Founder embryos were
analyzed in other lines. In constructs tg1k to tg3k-Del:5812-9918, a promoterless lacZ cassette was inserted into the 5 untranscribed region of
exon4, so that it was controlled by Pitx2c regulatory elements. Construct tg1k spans Pitx2c with about 6 kb of upstream flanking sequence and 4
kb of downstream flanking sequence. Construct tg3k was generated by adding a 7-kb genomic fragment (blue line) downstream to tg1k. Construct
tg2k was generated by deleting a 3-kb fragment upstream of P2 from tg3k. Construct tg3k-Del:5812-9918 was generated by deleting a 4-kb fragment
in the middle of a 7-kb fragment in tg3k. Numbers (0k through 12k) show the relative location of the deleted fragment downstream to exon 6.
Expression patterns from tg1k, -2k, and -3k indicated that the 7-kb fragment is essential for Pitx2c pituitary expression and the pattern from
tg3k-Del:5812-9918 indicates that the deleted 4-kb fragment is dispensable for Pitx2c pituitary expression. (B) Ventral-caudal view of Pitx2c in situ
hybridization of the head of a wild-type embryo (11.5 dpc). The mandible was cut off and is shown in panel C. Arrows indicate oral ectoderm and
RP hybridization signals. (D to K) Whole-mount X-gal staining and sagittal sections of different stages of tg3k transgenic embryos. (D and E) X-gal
staining of tg3k embryos at 11.5 dpc. The mandible was cut off and is shown in panel E. Arrows indicate LacZ staining in RP and oral ectoderm
with LacZ absence in the ectoderm of the frontonasal process and most distal mandible (dotted line). (F) Sagittal section of an embryo (11.5 dpc)
showing LacZ in RP (arrow). (G to H) Whole-mount X-gal staining of oral cavities of tg3k embryos at 14.5 dpc (G) and 13.5 dpc (H). Sagittal
sections showed that LacZ was expressed in molar tooth (I), pituitary (J), and tongue epithelium (K) in 13.5-dpc embryos. Abbreviations: fn, frontal
nasal process; md, mandible; di, diencephalon; ru, rugae; ps, palatal shelf; t, tongue; p, pituitary; mo, molor; mc, meckel cartilage. , absence of
oral ectoderm expression; , presence of oral ectoderm expression.
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deleted region may have a negative regulatory role (not
shown).
Pitx2 is expressed in the stomatodeal ectoderm that gives rise
to RP, beginning at 8.5 days postcoitum (dpc) (33). At 11.5
dpc, Pitx2c is expressed in the oral ectoderm of the maxillary
and mandibular processes, as well as RP that will give rise to
the anterior pituitary (Fig. 1B and C). LacZ staining indicated
that tg3k directed LacZ activity in oral ectoderm and RP at
11.5 dpc (Fig. 1D, E, and F). Notably, oral ectoderm expres-
sion was biased toward the proximal aspect of the branchial
arch (Fig. 1D and E). At 13.5 and 14.5 dpc, LacZ activity was
detected in the oral ectoderm, rugae of the secondary palate,
dental epithelium, and pituitary (Fig. 1G to K). LacZ activity
was also detected in the epithelium of the tongue, as has also
been shown by immunohistochemistry (Fig. 1H and K) (21). In
dental epithelium and the pituitary, LacZ staining was con-
fined to a subpopulation of cells in each organ, indicating that
the tg3k transgene lacked elements that direct endogenous
Pitx2c expression throughout the dental epithelium and ante-
rior pituitary. Taken together, these data indicate that the tg3k
construct contains elements that direct Pitx2c expression in
oral ectoderm and RP but lack other elements that are neces-
sary for complete Pitx2c expression in dental epithelium and
anterior pituitary.
Identification of a Pitx2c RP enhancer element. We next
investigated whether the 7-kb fragment was sufficient to direct
LacZ activity in oral ectoderm and RP. The 7-kb fragment was
inserted upstream of the Hsp LacZ construct that contained
the Hsp heterologous promoter element to generate the tg4k
construct. An analysis of founder embryos carrying the tg4k
construct indicated that the 7-kb region was sufficient to direct
LacZ activity in the RP but not in the oral ectoderm (Fig. 2A
to F). Next, we wanted to narrow down the critical region for
RP expression. Based on data from the tg3k Del 5821-9918
construct (Fig. 1) that indicated that the Pitx2c enhancer re-
sided at either the 5 or 3 end of the 7-kb fragment, we
subcloned the 5 and the 3 regions from the 7-kb fragment
upstream of Hsp LacZ and tested for LacZ activity in founder
embryos. This analysis indicated that the RP enhancer element
was contained in the 1.8-kb sequence at the 5 end of the 7-kb
fragment (Fig. 2A, G, and H).
Fine mapping the RP enhancer element. To further define
the region that directs the expression of LacZ in RP, we per-
formed a deletion analysis. The Pitx2c 1.8-kb fragment was
FIG. 2. Localization of the Pitx2c RP enhancer. (A) Construct names are indicated on the left, and the corresponding expression patterns are
summarized on the right. The “# with expression” column shows the number of transgenic lines with positive RP and oral ectoderm staining per
total number of transgenic lines. Constructs tg4k, -5k, and -6k were generated by fusing fragments from the 7-kb fragment to the Hsp68 LacZ
reporter. X-gal expression of tg4k, -5k, and -6k indicated that the first 1.8-kb fragment of 7 kb was sufficient to initiate Pitx2c expression in RP.
(B to H) Whole-mount X-gal staining of heads (11.5 dpc) of mice from transgenic lines, with mandibles removed. Constructs are labeled. Arrows
denote RP, and asterisks denote no LacZ staining in RP. , absence of RP expression; , presence of RP expression.
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subdivided into three fragments and subcloned upstream of
Hsp LacZ (Fig. 3A). Three out of eight transgenic embryos
carrying tg5K-1, which contained 520 bp at the 5 end of the
1.8-kb fragment, had robust LacZ activity (Fig. 3A, B, and C).
In contrast, embryos carrying tg5K-2 and tg5K-3 failed to show
LacZ activity in RP; moreover, we tested three other con-
structs containing deletions within the 1.8-kb fragment
(tg5K-4, tg5K-5, and tg5K-6) and the analysis of these three
lines revealed that the 520 bp at the 5 end of the 1.8-kb
fragment was common to all constructs with activity in RP.
Taken together, these findings indicate that the Pitx2c RP
enhancer is contained in the 520-bp fragment in tg5K-1 (Fig.
3A). We noted that construct tg5K-5 directed very efficient
LacZ expression, indicating that there may be sequence ele-
ments located outside the 520-bp element that contribute to
Pitx2c pituitary expression. Future experiments will be re-
quired to evaluate this possibility in more detail.
LEF-1 and NF-1X bind to the RP enhancer. We used the
rVISTA software program to compare human and mouse se-
quences and identified an NF-1 binding site at positions 175 to
189 of the 520-bp enhancer. We also found a consensus TCF/
LEF binding site that was just downstream of the NF-1 site in
the mouse sequence but that was weakly conserved in the
human sequence (Fig. 4A). Next, we used Clustal X to analyze
potential conservation of the NF-1 and TCF/LEF sites among
different species (mouse, rat, human, and chimp). Alignments
indicated that the NF-1 site was well conserved, while the
TCF/LEF site was weakly conserved (Fig. 4B).
To determine whether the NF-1 and TCF/LEF binding sites
in the 520-bp enhancer were capable of binding to NF-1 and
TCF family members in vitro, we first performed EMSAs. As
shown in Fig. 5, in vitro-translated NF-1X was capable of
binding to the NF-1 element with high affinity; moreover, the
binding of NF-1X to the NF-1 element was efficiently com-
peted by the wild-type NF-1 site but not by the mutated NF-1
site, indicating that binding was specific (Fig. 5A and B). The
identity of the NF-1 binding complex was further confirmed by
a supershift assay with anti-NF-1 antibody (Fig. 5B). The
EMSA also showed that purified LEF-1 protein efficiently
bound to the TCF/LEF binding site in the Pitx2c RP enhancer
and was specifically competed by wild-type competitor but not
by a mutant oligonucleotide (Fig. 5C). We noted a second
TCF/LEF binding site embedded within the 5 end of the NF-1
element (Fig. 4B). However, gel shift experiments using this
site failed to show specific binding activity (not shown). There-
fore, we focused on the more 3 TCF/LEF element.
To establish that NF-1 and TCF/LEF factors bound the
520-bp enhancer element in the native chromatin environ-
ment, we performed ChIP assays in T3 pituitary cells. We
used antibodies specific for NF-1 and LEF-1 in ChIP assays as
described previously (14); moreover, T3 cells endogenously
express NF-1 and LEF-1, allowing us to investigate transcrip-
FIG. 3. Fine mapping of Pitx2c RP enhancer. (A) A 1.8-kb Pitx2 downstream fragment was fused to Hsp68 LacZ to generate tg5k. Different
regions of a 1.8-kb fragment were fused to Hsp68 LacZ to generate constructs tg5k-1 through tg5k-6. In the nucleotides column, the relative
location in or deletion from tg5k of each construct is shown. (B to E) Whole-mount X-gal staining of heads (11.5 dpc) of mice from transgenic
lines, with mandibles removed and constructs labeled. 	, sense orientation; 
, antisense orientation. Arrows denote RP, and asterisks denote no
LacZ staining in RP. , absence of RP expression; , presence of RP expression.
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tion factor binding to the Pitx2c enhancer using endogenous
levels of protein. ChIP assays revealed that both NF-1 and
LEF-1 can specifically bind to the Pitx2c RP enhancer in the
native chromatin environment (Fig. 6A to C).
TCF-dependent and NF-1-dependent regulation of Pitx2c in
RP. To determine whether the NF-1 and TCF/LEF sites were
required for transgene expression in vivo, we generated con-
structs with mutations in the NF-1 (tg5k-NF-1 M) and TCF/
LEF (tg5k-TCF/LEFM) sites in the context of the 1.8-kb en-
hancer element. Of 12 embryos transgenic for the tg5k-NF-1 M
construct, 6 failed to show LacZ staining, while another 5 had
very weak LacZ activity after 48 h of staining for LacZ (Fig. 7A
and B and data not shown). One embryo expressed LacZ in RP
at a level similar to that of the wild-type construct (not shown).
This embryo also had LacZ expression in other regions of the
embryo, such as the limb muscle and eye, suggesting that the
integration site was in a region that was permissive for high
levels of transcriptional activity. These findings indicate that
the NF-1 site is required for optimal transcriptional activity of
the Pitx2c RP enhancer in most chromatin environments. How-
ever, as revealed by the one embryo that expressed LacZ in RP
at a level similar to that of the wild type, the NF-1 site is
dispensable for LacZ activity in chromatin environments that
are permissive for transcriptional activity.
In six embryos transgenic for the tg5k-TCF/LEFM con-
struct, all embryos failed to show LacZ activity even after
prolonged incubation in LacZ staining buffer (Fig. 7A and B).
This result indicates that the TCF/LEF site is required for
transcriptional activity of the Pitx2c RP enhancer.
NF-1 has also been implicated in regulating the pituitary-
specific POU factor, Pit-1, and the growth hormone gene, and
NF-1X was expressed in the mouse gonadotrope cell line
TCF/LEFNF-1
FIG. 4. Multispecies alignment of NF-1 and LEF-1 binding sites in Pitx2c pituitary enhancer. (A) One conserved NF-1 and one TCF/LEF
binding site were identified in tg5k-1 between mouse (mus) and human (homo). (B) NF-1 and TCF/LEF binding site alignments among more
species. Asterisks indicate conserved nucleotides.
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T3-1 (data not shown) (13, 36). However, it is unknown
whether NF-1 genes are expressed in RP. To address this issue,
we performed in situ analysis with all four NF-1 genes and
found that NF-1B was weakly expressed in the oral ectoderm
surrounding RP while NF-1X was weakly expressed in RP (Fig.
7C). This result suggests that NF-1X is the NF-1 gene that
regulates the Pitx2c RP enhancer.
DISCUSSION
Pitx2 is an early marker of undifferentiated oral ectoderm,
while at later stages, Pitx2 expression becomes restricted to
dental epithelium and RP. The identification of factors acting
upstream of Pitx2 will provide insight into the mechanisms that
establish oral ectoderm and define the organ-forming epithelia
of teeth and the pituitary. We identified a 520-bp region of the
Pitx2 gene that directs LacZ expression in RP. EMSA, ChIP,
and mutational analysis in transgenic embryos indicated that
both the NF-1 and TCF/LEF elements were critical for normal
levels of Pitx2c transcription in RP. Our findings uncover a role
for NF-1- and TCF-mediated regulation of Pitx2c transcription
in the developing pituitary and provide insight into the mech-
anisms regulating regional gene expression in the oral ecto-
derm.
Regulation of the Pitx2c RP enhancer by NF-1. The NF-1
family contains four homologous members, NF-1A, NF-1B,
NF-1C, and NF-1X. In vitro experiments have shown that NF-1
factors act both as transcriptional repressors and activators,
depending on the context (19). More recent work has shown
that NF-1 can influence transcription by remodeling chromatin
(15). Our findings indicate that the requirement for NF-1 bind-
ing to the Pitx2c RP enhancer was necessary for optimal tran-
scriptional activity. Some embryos transgenic for the NF-1
mutant construct showed low transcriptional activity; more-
over, the requirement for NF-1 binding could rarely be over-
come, for example, when the transgene integrated into a region
of high transcriptional activity.
The transcriptional regulatory functions of NF-1 have been
studied in the context of the mouse mammary tumor virus
promoter. In this system, NF-1 is required for full transcrip-
tional activity by stabilizing the chromatin structure and allow-
ing other factors to bind (15). In Xenopus oocytes, NF-1 coop-
erates with Oct-1 to stabilize an intermediate chromatin
structure and likely acts as a platform to recruit other factors
(3, 4). Consistent with this notion, NF-1 has been shown to
occupy the glial fibrillary acidic protein promoter prior to the
differentiation of astrocytes and cooperates with AP1 in astro-
cytes to regulate gene expression but fails to activate expression
FIG. 5. NF-1X and LEF-1 bind to the Pitx2c RP enhancer in vitro. (A) Schematic representation of the 525-bp minimal Pitx2c pituitary
enhancer region (tg5k-1). -32P-labeled oligonucleotides for the NF-1 binding site and LEF-1 binding site of the Pitx2c pituitary regulatory region
were used as probes in gel mobility shift assays. Underlined nucleotides indicate changes from the consensus binding sequence. (B) In vitro-
translated NF-1X protein was used in lanes 2 to 4, and nuclear extracts from T3-1 cells were used in lanes 5 and 6. (C) Purified LEF-1 protein
from cell lysates was used in lanes 2 to 4. Ab, antibody; Mut, mutant; WT, wild type; , absence of; , presence of.
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on its own (7, 18). Our data indicate that NF-1 may have an
analogous function as a potentiator of Pitx2c transcription in RP.
Pitx2c, a target of Wnt signaling in pituitary development. In
the presence of Wnt signaling, -catenin is stabilized and en-
ters the nucleus, where it interacts with TCF factors, such as
LEF-1 or TCF4, to induce downstream gene expression. In the
absence of Wnt signaling, -catenin is targeted for destruction
by the APC, Axin, Gsk3b complex that phosphorylates -cate-
nin and directs it to a destruction pathway (22). Canonical Wnt
signaling has been shown to be important during pituitary
lineage diversification by promoting Pit1 and repressing Hesx1
expression (34). Other experiments indicated that TCF4 had a
role in pituitary expansion by influencing anterior pituitary
growth while the noncanonical Wnt, Wnt5a, played a role in
regulating cell shape (6, 8).
Canonical Wnt signaling is functional in the pituitary during
the time window (11.5 to 14.5 dpc) that we focused on in our
study, supporting the idea that Pitx2c in RP is regulated by a
canonical Wnt signal (34). Previous work showed that TCF3
and TCF4 are expressed in RP at the 11.5 and 12.5 dpc stages
that we studied in our analysis of the Pitx2c RP enhancer,
suggesting that they are the TCF factors regulating Pitx2c ex-
pression. Our data also indicate that LEF-1 binds efficiently to
the Pitx2c RP enhancer in gel shift and in ChIP assays. In
addition, LEF-1 is expressed transiently in RP, supporting the
notion that LEF-1 is involved in the early induction of Pitx2c
RP expression (34).
The loss of the TCF/LEF recognition element in the Pitx2c
RP enhancer resulted in a complete loss of transcriptional
activity, revealing that this is a functional binding site. In our
interspecific sequence alignments, we noted that the TCF/LEF
binding site was weakly conserved between mouse and human.
Phylogenetic sequence conservation is an extremely powerful
tool for determining functional transcription factor binding
sites (35). However, there is strong evidence that evolutionary
genetic drift can result in point mutations or deletions that
disrupt functional transcription factor binding sites and also
introduce compensatory mutations that maintain normal gene
expression (31). The result of such events would be failure to
conserve the location of a functional transcription factor bind-
ing site.
Previous studies suggested that Pitx2a was regulated in pi-
tuitary cells by canonical Wnt signaling (23). Consensus TCF/
LEF binding sites identified upstream of Pitx2a were shown to
respond to Wnt signals and bind LEF-1 in tissue culture cells
(23). Although it is unknown whether this element directs
Pitx2a expression in RP, it will be important in the future to
determine whether the different TCF/LEF binding elements
interact to direct the expression of the Pitx2a and Pitx2c iso-
forms in RP. Taken together, our data implicate Wnt signaling
FIG. 6. LEF-1 and NF-1 bind to the Pitx2c pituitary enhancer in vivo. (A) Schematic of the Pitx2c promoter and pituitary enhancer with the
LEF-1 and NF-1 binding sites noted. The locations of the sense primer and the antisense primer are indicated by arrows. (B) ChIP assays were
performed using T3 cells. Lane 2 shows the LEF-1 immunoprecipitated chromatin amplified using the specific Pit2c promoter primers. The
product was the correct size (390 bp). Lane 3 shows Pitx2c primers only. Lane 6 shows the LEF-1 immunoprecipitated chromatin amplified with
primers to an unrelated gene. (C) ChIP assays were performed as described for panel B, except the NF-1 antibody was used to immunoprecipitate
the chromatin.
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in the diversification of the oral ectoderm into the organ-
forming epithelium of RP.
Implications for mechanisms regulating Pitx2 transcription.
Previous studies uncovered a two-step mechanism that func-
tioned through the ASE, regulating Pitx2c in the lateral plate
mesoderm and individual organ primordia. The induction of
Pitx2c was dependent upon the Nodal-signaling cascade that
works through the FoxH1 effector. The second phase of Pitx2c
transcription, dependent upon an Nkx binding site in the ASE,
was not required for induction but was essential for Pitx2c tran-
scriptional maintenance. Therefore, the mechanism involved in
Pitx2c regulation through the ASE likely reflects sequential bind-
ing of transcriptional activators, since transgenes with either ele-
ment still express at the appropriate developmental stage (42, 43).
FIG. 8. A model for the regulation of Pitx2c transcription in RP. Schematized model showing factors that regulate Pitx2c transcription in RP.
NF-1 and TCF/LEF-1 binding and canonical Wnt signaling are required for optimal Pitx2c RP enhancer activity (left panel). A function for NF-1
in potentiation of Wnt-induced Pitx2c transcriptional activation in RP is proposed. The absence of Wnt signaling or the mutation of the TCF/LEF
element results in a loss of Pitx2c RP enhancer activity (middle panel). The loss of NF-1 binding, through mutation of the NF-1 element, results
in inefficient Pitx2c RP enhancer activity (right panel).
FIG. 7. Mutations within the NFI or TCF/LEF recognition elements in transgenic embryos. (A) NF-1 and LEF-1 individual mutations were
made on the background of tg5k (1.8-kb Pitx2 element). An asterisk indicates a mutant recognition element. , absence of RP expression; ,
presence of RP expression. fn, frontal nasal process; mp, maxillary process. The “# with expression” column shows the number of transgenic lines
with positive RP staining per total number of transgenic lines. (B) Whole-mount X-gal staining of heads (11.5 dpc) of mice from transgenic lines,
with mandibles removed and constructs labeled. (C) Whole-mount in situ with NF-1B and NF-1X probes at 11.0 dpc. Arrows indicate signal in
oral ectoderm (for NF-1B) or RP (for NF-1X). The asterisk indicates lack of expression in Rathke’s pouch.
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Although both NF-1 and TCF/LEF factors are expressed
in RP, neither NF-1 nor TCF factors are pituitary specific,
suggesting the possibility of a cooperative interaction be-
tween these two factors in Pitx2c RP regulation. We propose
a model in which NF-1 binding to the Pitx2c RP enhancer
induces a potentiation of transcription by NF-1, followed by
signal-induced transcriptional activation mediated through
the TCF/LEF binding site (Fig. 8). TCF/LEF elements have
often been shown to function cooperatively with other ele-
ments in developmental systems (2, 5); moreover, in other
systems, NF-1 is known to function as a transcriptional po-
tentiator in certain contexts (3). Alternative models are also
possible. For example, it is possible that the NF-1 and TCF/
LEF elements function independently. In this model, there
may be other pituitary-specific factors that function cooper-
atively with the NF-1 or TCF/LEF elements to direct Pitx2c
transcription. Further experiments are warranted to inves-
tigate this possibility.
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